Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT
Kim Papp, José M. López Pinto, Keiichi Yamanaka, Jérémy Lambert et al.
Journal
Dermatology and Therapy
Topics
Psoriasis: Treatment and Pathogenesis
article
Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT
Kim Papp, José M. López Pinto, Keiichi Yamanaka, Jérémy Lambert, Krista Wixted, L. Savage, Diamant Thaçi, Rhys Warham, April W. Armstrong, Mark Lebwohl, Diana Elena Vlase
article en
Abstract
No abstract available for this paper.
Publication Tag
Dermatology and TherapyVol. 16(1)
Institutions
APLA Health (US), University of California, Los Angeles (US), Mie University (JP), University of Toronto (CA), Leeds Teaching Hospitals NHS Trust (GB), UCB Pharma (France) (FR), Probity Medical Research (CA), Digital Research Alliance of Canada, National Patient Safety Foundation (US), University of Lübeck (DE), Icahn School of Medicine at Mount Sinai (US)